Welcome to our dedicated page for APTARGROUP SEC filings (Ticker: ATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AptarGroup, Inc.'s SEC filings document operating results, governance matters and capital-structure activity for a NYSE-listed maker of drug delivery and consumer-product dispensing technologies. Form 8-K reports furnish quarterly and annual results, segment commentary for Pharma, Beauty and Closures, shareholder returns and material events tied to the company's operations.
The filing record also includes proxy materials and annual meeting vote results covering director elections, advisory compensation matters and stockholder voting items. Capital disclosures include common stock registered under the Exchange Act, shelf-registration activity and completed debt financing, including the 4.750% Senior Notes due 2031 issued under an indenture.
Candace S. Matthews, a director of AptarGroup, Inc., reported a grant/award acquisition of 226 shares of Common Stock on 2026-07-16 at a stated price of $0.00 per share. Following this award, she directly holds 8,101 shares of Common Stock. The Rule 10b5-1 checkbox was not selected.
APTARGROUP, INC. director Ralf K. Wunderlich received a grant of 151 shares of Common Stock on July 16, 2026, reported at $0.0000 per share as a grant/award acquisition. After this award, he directly owns 18,690 shares of AptarGroup common stock. The transaction was not reported under a Rule 10b5-1 trading plan.
APTARGROUP, INC. director B Craig Owens reported a grant/award acquisition of 151 shares of common stock on 2026-07-16, at a reported per-share price of $0.0000. Following this equity award, his directly owned holdings increased to 11,233.592 shares of common stock.
APTARGROUP, INC. director Sarah JS Glickman reported a grant, award, or other acquisition of 151 shares of Common Stock on 2026-07-16. The shares were reported at a per-share price of $0.0000, indicating a no-cash stock award. Following this transaction, she directly holds 4,553 shares of AptarGroup common stock.
Xing Julie reported acquisition or exercise transactions in this Form 4 filing.
Director Julie Xing of AptarGroup, Inc. reported receiving a grant of 151 shares of Common Stock on 2026-07-16 at $0.00 per share. Following this award, she directly owns 5,242 shares of AptarGroup Common Stock.
Matthew L. Trerotola, a director of AptarGroup, Inc., received a grant of 151 shares of common stock on 2026-07-16, reported as a “Grant, award, or other acquisition.” Following this award, his directly held common stock position totals 9,306.85 shares.
Gandhi Aditya reported acquisition or exercise transactions in this Form 4 filing.
APTARGROUP, INC. reported that Chief Accounting Officer Aditya Gandhi received a grant of common stock as compensation. The award covers 2,664 shares of Common Stock at a stated price of $0.0000 per share. Following this grant, Gandhi directly holds 2,664 common shares, reflecting an initial equity position rather than an open-market purchase or sale.
APTARGROUP, INC. Segment President Marc Prieur reported open-market sales of company common stock. On June 9, 2026, he sold a total of 5,000 shares in two non-derivative transactions at weighted average prices around $115–$116 per share, based on multiple individual trades within stated price ranges.
APTARGROUP, INC. filed an initial Form 3 for officer Aditya Gandhi, who serves as Chief Accounting Officer. This filing establishes him as a reporting person for insider holdings and trades. The data provided shows no reported transactions or holdings in this Form 3.